Diabetes & Endocrinology
Global

Diabetes & Endocrinology Experts

Thomas Dyrberg

MD
DIABETES IMMUNONLOGY
Nuvelution Pharma, Inc.
United States of America

Biography

 Thomas Dyrberg, MD joined Novo A/S in 2000. He is a member of the Boards of Directors of Delenex Therapeutics AG, Ophthotech Corporation, PanOptica Inc., and Veloxis Pharmaceuticals A/S. Dr. Dyrberg held research positions at the Hagedorn Research Institute, Denmark, and at the Scripps Research Institute, La Jolla, US. In 1990, he joined Novo Nordisk A/S, initially working in Health Care Discovery on various aspects of diabetes immunology and pathogenesis, and from 1996 in Health Care Clinical Drug Development. Dr. Dyrberg obtained an MD degree from the University of Copenhagen in 1981 and a DMSc degree, also from the University of Copenhagen in 1986.

Research Interest

 DIABETES IMMUNONLOGY

Global Experts from United States of America

Global Experts in Subject

Share This Profile